Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer

Release Date: March 2007

---

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer.

Summary of Recommendation / Supporting Documents

---

Summary of Recommendation

• The USPSTF recommends against the routine use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer in individuals at average risk for colorectal cancer.
  Grade: D Recommendation.

Top of Page

---

Supporting Documents

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer, March 2007
Recommendation Statement (PDF File, 135 KB; PDF Help)
Aspirin for Primary Prevention of Colorectal Cancer: Systematic Review (PDF File, 300 KB; PDF Help)
Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: Systematic Review (PDF File, 330 KB; PDF Help)
Evidence Synthesis (PDF File, 3.6 MB; PDF Help)

Top of Page

Current as of March 2007

---

Internet Citation:

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer, Topic Page. March 2007. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsasco.htm

---